Related Experiment Video

Updated: Jun 16, 2026

Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens
09:33

Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens

Published on: August 25, 2023

1.2K

Identification of an unusual combination of actionable mutations through genomic profiling in a child with an

Shimaa Sherif1,2, Wouter R L Hendrickx1,2, Christophe Michel Raynaud1

  • 1Tumor Biology and Immunology Laboratory, Research Branch, Sidra Medicine, Doha, Qatar.

Pediatric Blood & Cancer
|October 17, 2023
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Detection and Monitoring of Tumor Associated Circulating DNA in Patient Biofluids
06:53

Detection and Monitoring of Tumor Associated Circulating DNA in Patient Biofluids

Published on: June 8, 2019

8.7K
Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors
11:15

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors

Published on: September 20, 2016

24.4K

Related Experiment Videos

Last Updated: Jun 16, 2026

Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens
09:33

Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens

Published on: August 25, 2023

1.2K
Detection and Monitoring of Tumor Associated Circulating DNA in Patient Biofluids
06:53

Detection and Monitoring of Tumor Associated Circulating DNA in Patient Biofluids

Published on: June 8, 2019

8.7K
Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors
11:15

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors

Published on: September 20, 2016

24.4K

Related Concept Videos

Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...

Articles linked to this work by shared authors, journal, and citation graph.

Globalising the access to advanced molecular diagnostics of CNS tumors: Experience of the Molecular Neuro-Pathology (MNP) Outreach Consortium.

Neuro-oncology·2026

SLFN11 enhances cisplatin sensitivity in pediatric cancer via activation of stress-response and suppression of survival pathways.

British journal of cancer·2026

HLA class I expression and tumor immune infiltration together shape colon cancer immune contexture.

Neoplasia (New York, N.Y.)·2026

Immune microenvironment and noncoding RNA shape early colorectal carcinogenesis in patients with premalignant lesions.

Science translational medicine·2026

A Three-Gene Interferon Signature Predicts Sustained Complete Remission in Pediatric AML Patients.

Cancers·2026

Enhancing the accuracy of molecular classification of pediatric CNS tumors: a dual-classifier approach using DNA methylation profiling.

Frontiers in oncology·2026

Bone and Soft Tissue Neoplasms in Infants Versus Older Children: A Report From the Cancer in Young People in Canada Program.

Pediatric blood & cancer·2026

A Novel VPS45 p.(His331Tyr) Variant Presenting With Severe Hypersplenism and Epstein-Barr Virus Reactivation: A Case Report.

Pediatric blood & cancer·2026

Impact of Initial Treatment Setting on Survival in Relapsed Pediatric and AYA Bone Sarcomas: A Secondary Analysis of a Prospective Clinical Trial.

Pediatric blood & cancer·2026

Pseudoexon Activation as a Novel Molecular Mechanism for Chediak-Higashi Syndrome.

Pediatric blood & cancer·2026

Successful Use of Sutimlimab in two Pediatric Patients With Refractory Cold Antibody-Mediated Autoimmune Hemolytic Anemia.

Pediatric blood & cancer·2026

Proton Radiotherapy Decreases Incidence of Radiation-Induced Second Malignant Neoplasms Compared to Photon Radiotherapy in Patients With Retinoblastoma.

Pediatric blood & cancer·2026

TCR sensitivity shapes recognition of tumor antigen presented by host cells and TCR-T cell efficacy in solid tumors.

Cancer immunology research·2026

Carbocisteine Confers Renoprotection in Streptozotocin-Induced Diabetic Nephropathy Through Sirt-1/Nrf-2-Dependent Inhibition of NLRP3 Inflammasome Activation.

Archiv der Pharmazie·2026

Supplementation with Akkermansia muciniphila Enhances the αPD-1 Efficacy in Mice Transplanted with Gut Microbiota from Patients with Colorectal Cancer.

Current cancer drug targets·2026

Ursolic Acid in Cancer Therapy: Mechanistic Insights into Apoptosis, Angiogenesis, Cell Cycle Arrest, and Metastasis.

Current molecular medicine·2026

Chalcone Derivatives as Multitarget Modulators of Signalling Pathways in Breast Cancer: Mechanisms, Challenges, and Future Perspectives.

Mini reviews in medicinal chemistry·2026

Dementia with Lewy bodies and amyloid pathology: Eligible for anti-amyloid treatment or not?

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us